Evidence map›Paper›PMID 26256466›Full record

ReviewBritish journal of clinical pharmacology2015

Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.

Kate O'Hara, Ian M R Wright, Jennifer J Schneider, Alison L Jones, Jennifer H Martin

Abstract readReview
In one paragraph

Review in British journal of clinical pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Beta-blockers and breastfeeding: a real-life prospective study.European journal of clinical pharmacology · 2024
    Article
  13. Topical review: Lactation and use of DMTs in women with MS.Multiple sclerosis (Houndmills, Basingstoke, England) · 2024
    Review
  14. Article
  15. Article
  16. Case Files from the University of California San Diego Medical Toxicology Fellowship: Neonatal Flecainide Toxicity from an Accidental Dosing Error.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kate O'HaraSchool of Medicine and Public Health, University of Newcastle, Newcastle.
Ian M R WrightUniversity of Wollongong and Illawarra Health & Medical Research Institute, Wollongong.
Jennifer J SchneiderSchool of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle.
Alison L JonesSchool of Medicine and Public Health, University of Newcastle, Newcastle.
Jennifer H MartinSchool of Medicine and Public Health, University of Newcastle, Newcastle.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paediatric patients, particularly preterm neonates, present many pharmacological challenges. Due to the difficulty in conducting clinical trials in these populations dosing information is often extrapolated from adult populations. As the processes of absorption, distribution, metabolism and excretion of drugs change throughout growth and development extrapolation presents risk of over or underestimating the doses required. Information about the development these processes, particularly drug metabolism pathways, is still limited with weight based dose adjustment presenting the best method of estimating pharmacokinetic changes due to growth and development. New innovations in pharmacokinetic research, such as population pharmacokinetic modelling, present unique opportunities to conduct clinical trials in these populations improving the safety and effectiveness of the drugs used. More research is required into this area to ensure the best outcomes for our most vulnerable patients.

Indexed as

PharmacokineticsAryl Hydrocarbon HydroxylasesCytochrome P-450 CYP1A2Cytochrome P-450 CYP2D6Cytochrome P-450 CYP3AHumansInfant, NewbornModels, BiologicalTissue DistributionAryl Hydrocarbon HydroxylasesCYP3A7 protein, humanCytochrome P-450 CYP1A2Cytochrome P-450 CYP2D6Cytochrome P-450 CYP3Aneonatepaediatricpharmacokineticspopulation pharmacokinetic modelling

Identifiers

PMID26256466
PMCPMC4693494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.